V. Haufroid et al., Biological monitoring of exposure to sevoflurane in operating room personnel by the measurement of hexafluoroisopropanol and fluoride in urine, BIOMARKERS, 5(2), 2000, pp. 141-151
The objectives of this study were to evaluate the value of urinary hexafluo
roisopropanol (HFIP) and fluoride (F-) measurement for the biological monit
oring of operating room personnel exposed to sevoflurane. Fifty members of
operating room staffs from eight different hospitals took part in the study
. To assess external exposure to sevoflurane, air samples were collected du
ring the whole anaesthesia period by a passive sampling device (3M 3500 org
anic vapour monitor) attached close to the breathing zone of each subject.
Urine was collected before (BA) and at the end of anaesthesia (EA) for the
determination of HFIP, fluoride and creatinine. Average airborne concentrat
ion of sevoflurane was 19.0 ppm (range: ND-139.9 ppm) with a mean duration
of anaesthesia of 221 min (range: 60-435 min). There was a better correlati
on between external and internal exposure as estimated by EA urinary HFIP (
r = 0.78; p<0.0001) compared with EA urinary F- (r = 0.41; p = 0.0031). Fur
thermore determination of urinary HFIP seemed more suited than that of F- f
or the assessment of sevoflurane exposure because of lower background in BA
samples (86 % of BA HFIP values were under the limit of detection). Based
on these results, values of 9.6 and 4.3 mg HFIP g(-1) creatinine correspond
to airborne concentrations of 50 and 20 ppm of sevoflurane, respectively.
Among the confounding parameters investigated (body mass index (BMI), sex,
cytochrome P450 polymorphism) only BMI showed statistically significant inf
luence on sevoflurane metabolism at these low levels of exposure. The measu
rement of HFIP in urine at the end of the surgical procedure constitutes a
good index to assess occupational exposure to sevoflurane. Further studies
will be necessary to propose an health-based limit value which remains to b
e determined from the relationship between effects and internal dose as can
be assessed by HFIP measurement in urine.